FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Azacitidine for Injection
Status: Currently in Shortage
»Date first posted: 12/18/2020
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 06/10/2021)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial (NDC 16729-306-10) Limited availability. Shortage of an active ingredient

Armas Pharmaceuticals Inc (Reverified 05/19/2021)

Company Contact Information:
1-732-637-1971

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial (NDC 72485-201-01) Limited availability Additional lots are manufactured. Product will be made available as it is released. Demand increase for the drug

Breckenridge Pharmaceutical (Revised 07/07/2021)

Company Contact Information:
860-828-8140

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial (NDC 51991-797-98) Available

Celgene Corporation (Reverified 05/19/2021)

Company Contact Information:
1-888-423-5436

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg single-dose vial in cartons of 1 vial, (NDC 0781-3253-94) Available Distributed by Sandoz, Inc. Contact number 800-525-8747
100 mg single-dose vial in cartons of 1 vial, (NDC 0781-9253-94) Available NOVAPLUS labeling. Distributed by Sandoz, Inc. Contact number 800-525-8747
VIDAZA, , 100 mg single-dose vial in cartons of 1 vial, (NDC 59572-102-01) Limited inventory, on allocation Demand increase for the drug

Cipla Limited (Revised 06/08/2021)

Company Contact Information:
844-247-5287

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial (NDC 69097-805-40) Available Check wholesalers for inventory Demand increase for the drug

Dr. Reddy's Laboratories, Inc. (Revised 09/08/2021)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial, (NDC 43598-305-62) Low inventory Partial shipments on allocation through September Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 09/23/2021)

Company Contact Information:
1-888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial, single dose vial, PF, (NDC 63323-771-39) Available Check wholesalers for inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 07/06/2021)

Company Contact Information:
1-800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial, (NDC 0143-9606-01) Inventory is currently available. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional, a Viatris company (Reverified 09/16/2021)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial (NDC 67457-254-30) Unavailable Other

Teva Pharmaceuticals (Reverified 09/20/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg/vial Lyophilized Powder (NDC 68001-0313-56) No supply disruption - we are meeting current demand. Product is manufactured and labeled for Blue Point Laboratories

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English